RecruitingNot Applicable

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Italy100 participantsStarted 2024-02-19

Plain-language summary

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Who can participate

Age range25 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HR-HPV DNA test positivity Exclusion Criteria: * No HSIL

What they're measuring

HPV DNA test negativity

Timeframe: 8 months of treatment

Trial details

NCT IDNCT06285357

SponsorLo.Li.Pharma s.r.l

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-03

Contact for this trial

Giovanni Grandi

+390594222830 giovanni.grandi@unimore.it

View on ClinicalTrials.gov More HPV Infection trials